Pascalite Clay Powder Deodorant Recall (F-1127-2013)
Pascalite, Incorporated recalled its clay powder product after FDA testing found violative levels of lead. The product was sold in 8 oz, 16 oz, 5 lb, and 25 lb containers and marketed for use as a deodorant and freshener. The recall was initiated in January 2013 and terminated in April 2013.
By RecallRadar Editorial Team
Sourced from FDA. Last verified April 24, 2026.
On this page
Free checker
Check if you qualify
See whether your device may qualify for a free repair or replacement program before you spend money.
Check if you qualifyKey facts
- Date announced
- January 2, 2013
- Source agency
- FDA
This recall affects device functionality. Consider taking action soon.
✨ Plain-English Summary
Pascalite, Incorporated recalled its clay powder product after FDA testing found violative levels of lead. The product was sold in 8 oz, 16 oz, 5 lb, and 25 lb containers and marketed for use as a deodorant and freshener. The recall was initiated in January 2013 and terminated in April 2013.
Is This Recall Still Active?
Status: No - Expired
This recall is no longer active. You can still review details here for historical reference and confirmation.
What's Being Recalled
Quoted source excerpt from the official notice.
Pascalite Clay Powder recalled because it may contain violative levels of lead. The powder was marketed as a deodorant and freshener.
Quick Info
Key facts from the official notice, kept in the article flow for easy cross-checking.
- Brand
- Pascalite
- Category
- food
- Source agency
- FDA
- Announced
- January 2, 2013
- Country
- US
- Status
- Expired
Who's Affected
Specific models and identifiers listed in the source notice:
Model #1
All Pascalite powder products in 8 oz, 16 oz, 5 lb, and 25 lb containers
| # | Model |
|---|---|
| 1 | All Pascalite powder products in 8 oz, 16 oz, 5 lb, and 25 lb containers |
Technical model codes are manufacturer identifiers. Match both the product name and model code from your device settings, label, or packaging.
What You Should Do
Follow the remedy path from the official notice using the exact model and serial details above.
- 1Stop using Pascalite Clay Powder immediately.
- 2Do not apply to skin or use as a deodorant.
- 3Keep the product out of reach of children.
- 4Contact Pascalite at 307-347-3872 for disposal instructions.
This program has ended. The official source page may no longer be available.
Source & Verification
This page summarizes the official notice and keeps key facts easy to verify.
- Official source
- FDA
- Announced by source
- January 2, 2013
- Last reviewed by RecallRadar
- April 24, 2026
Frequently Asked Questions
Am I affected by this recall?
Check the affected models section on this page. The official notice currently lists All Pascalite powder products in 8 oz, 16 oz, 5 lb, and 25 lb containers.
What is the remedy for this recall?
1. Stop using Pascalite Clay Powder immediately. 2. Do not apply to skin or use as a deodorant. 3. Keep the product out of reach of children. 4. Contact Pascalite at 307-347-3872 for disposal instructions. 5. Consult a healthcare provider if you have concerns about lead exposure.
Where can I verify recall details?
Use the official source link in this page to confirm dates, eligibility, and next steps: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts
Keep browsing with these internal hubs: Pascalite recall hub and Food & Drug recall hub.
Official Resources
Use these primary sources for final eligibility and claim instructions.
View official notice from FDASee an inaccuracy?
Help us improve the accuracy of this recall information.
On this page
Free checker
Check if you qualify
See whether your device may qualify for a free repair or replacement program before you spend money.
Check if you qualifyKey facts
- Date announced
- January 2, 2013
- Source agency
- FDA
Related Recalls
BD ChloraPrep Clear, (2% w/v chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol), 60 x 1 mL applicators/carton, 0.03fl oz (1 mL) each, STERILE SOLUTION, CareFusion 123, LLC, El Paso, TX, subsidiary of Beckton, Dickson and Co. NDC 54365-400-31
Lack of Assurance of Sterility: Affected product may exhibit an open or incomplete seal on the packaging of the applicator
Jul 22, 2026
CLEVIPREX (clevidipine injectable emulsion) 50 mg/100 mL (0.5 mg/mL), 10 Single Use Vials, Rx Only, Manufactured for: Chiesi USA, Inc., Cary, NC 27518, by Fresenius Kabi, Graz, Austria, NDC 10122-611-10.
Lack of Assurance of Sterility
Jul 22, 2026
QC Quality Choice, Carbamide Peroxide, 6.5%, 0.5 FL. OZ. (15 mL) a) Washer Bulb included (NDC 63868-026-15); b) 1 bottle (NDC 63868-027-16), Distributed by C.D.M.A., Inc., 43157 W. Nine Mile, Novi, MI 48376.
SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%).
Jul 22, 2026
Clinere, Carbamide Peroxide, a) 2 bottles of Clinere Carbamide Peroxide (2 x 0.50 mL) 6.5%, 0.5 fl. oz. (15 mL); b) 1 bottle of Clinere Carbamide Peroxide (0,50 fl. oz. (15 mL), Dist. by: Quest Products LLC, Pleasant Prairie, WI 53158, NDC 68229-102-01.
SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%).
Jul 22, 2026
LEADER, Carbamide Peroxide 6.5%, 0.5 Fl Oz (15 mL), a) Kit -1 RUBBER BULB SYRINGE, 0.5 FL OZ DROPS, (NDC 70000-0689-1); b) 1 bottle (NDC 70000-0688-1), DIST. BY CARDINAL HEALTH, DUBLIN, OH 43017.
SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%).
Jul 22, 2026